ISRCTN21269614已完成未知
Insulin action and hypertension: effects of hyperaldosteronism and its treatment
Belfast Health and Social Care Trust (UK)0 个研究点目标入组 16 人开始时间: 2008年9月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients aged under 70 years, either sex
- •2. Mild essential hypertension
排除标准
- •1. Presence of diabetes mellitus
- •2. Significant obesity (body mass index [BMI] exceeding 35 kg/m^2)
- •3. Cardiac, renal or hepatic disease
- •4. A history of gout
- •5. Any treatment that may affect insulin action
- •6. Hyperkalaemia
- •7. Taking potassium sparing diuretics, potassium supplements or strong inhibitors of CYP 34A
- •8. Women who are pregnant or breastfeeding
- •9. Secondary hypertension
- •10. Diastolic blood pressure outside 80 - 105 mmHg range after placebo run-in of six weeks
- •11. Not capable of giving informed consent
研究者
相似试验
进行中（未招募）
不适用
Insulin action and hypertension: effects of hyperaldosteronism and its treatment.The effect of eplerenone on insulin action is being studied in patients with mild essential hypertension.EUCTR2007-004689-42-GBBelfast Health and Social Care Trust
终止
不适用
Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic ComplianceInsulin SensitivityAortic ComplianceDiastolic FunctionNCT01252238Brigham and Women's Hospital24
已完成
不适用
Insulin and Biogenic Amines in Cardiovascular DiseaseCardiovascular DiseasesHeart DiseasesObesityMyocardial InfarctionHypertensionInsulin ResistanceNCT00005194National Heart, Lung, and Blood Institute (NHLBI)
撤回
不适用
Effects of Insulin on Hypotension and SarcopeniaSarcopeniaHypotension, OrthostaticDiabetesNCT03248271Kenneth Madden
已完成
4 期
Effects of Pioglitazone in Hypertensive PatientsHypertensionInsulin ResistanceNCT01472497Tottori University Hospital16